查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1649478

OTC 睡眠辅助剂市场预测（2025-2030 年）

Otc Sleep Aids Medication Market - Forecasts from 2025 to 2030
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 144 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

非处方睡眠辅助药物市场预计将以 4.89% 的复合年增长率成长，从 2025 年的 201.05 亿美元成长至 2030 年的 255.26 亿美元。

非处方（OTC）睡眠辅助剂是无需处方笺即可购买的用于治疗失眠或睡眠不足的药物。如果失眠现像不频繁，通常建议使用这些药物。常用的非处方助眠药包括苯海拉明、多西拉敏、褪黑激素和缬草。这些产品的市场包括 Unison SleepTabs、ZzzQuil、Tylenol、Nytol 和 Sominex 等知名品牌。非处方睡眠辅助药物市场包括非处方笺睡眠药物和天然补充剂的生产、分销和销售，用于治疗偶尔失眠、轻度失眠、暂时性睡眠障碍、时差和一般烦躁不安。这个市场包括抗组织胺、褪黑激素补充剂以及缬草根和洋甘菊等草药。非处方睡眠辅助药物市场的成长受到多种因素的推动。睡眠障碍盛行率的上升很大程度上是由于现代生活方式的改变，例如压力、焦虑、不规则的工作时间以及过多的萤幕时间。由于这些因素，睡眠障碍很常见。随着人们越来越意识到睡眠健康的重要性，对安眠药和天然补充品来解决睡眠问题的需求也越来越大。此外，非处方药供应的增加也促进了该市场的持续成长。此外，天然和草本助眠剂的流行趋势明显，预计将进一步推动市场成长。

OTC睡眠辅助剂市场驱动因素：

  • 睡眠障碍盛行率上升：现代生活方式以压力、焦虑、工作压力和过多萤幕时间为特征，导致患有失眠和异睡症等睡眠障碍的人数显着增加。根据美国国家心肺血液研究所的资料，大约有 5,000 万至 7,000 万美国人患有睡眠或觉醒障碍。此外，成人慢性失眠评估和管理临床指引估计，约 33% 至 50% 的成年人面临情境压力。这些统计数据显示失眠呈成长趋势，并预示非处方睡眠辅助药物市场在未来几年将大幅成长。

非处方睡眠辅助剂市场的地理模式：

  • 亚太地区预计成长最快：非处方睡眠辅助药物市场分为北美、南美、欧洲、中东和非洲以及亚太地区。由于与现代生活方式相关的睡眠障碍病例不断增加，预计亚太地区将成为预测期内成长最快的地区。经济状况的改善使得消费者有能力购买这些药物。此外，人们对睡眠相关疾病及其治疗方法的认识也得到了提升。

另一方面，北美由于其发达的医疗保健基础设施预计将保持较大的市场份额。总而言之，随着人们对睡眠健康问题的认识不断提高、对针对失眠和相关疾病的有效解决方案的需求不断增加、产品配方的进步以及特别是在亚太地区的重大发展，非处方睡眠辅助市场将迎来强劲增长。

为什么要购买这份报告？

  • 深刻分析：获得深入的市场洞察，涵盖主要和新兴地区，重点关注客户群、政府政策和社会经济因素、消费者偏好、垂直行业和其他子区隔。
  • 竞争格局：了解全球主要企业所采用的策略策略，并了解正确策略带来的潜在市场渗透率。
  • 市场趋势和驱动因素：探索动态因素和关键市场趋势以及它们将如何影响未来的市场发展。
  • 可行的建议：利用洞察力做出策略决策，在动态环境中开闢新的业务流和收益。
  • 受众广泛：对于新兴企业、研究机构、顾问公司、中小企业和大型企业都有益且具有成本效益。

它有什么用途？

产业与市场分析、商业机会评估、产品需求预测、打入市场策略、地理扩张、资本支出决策、法律规范与影响、新产品开发、竞争影响

研究范围

  • 2022 年至 2030 年的实际资料和预测
  • 成长机会、挑战、供应链前景、法规结构、顾客行为、趋势分析
  • 竞争定位、策略与市场占有率分析
  • 细分和区域分析，包括收益成长和预测国家
  • 公司概况（策略、产品、财务、主要发展等）

OTC 睡眠辅助药物市场细分如下：

按类型

  • 抗组织胺药物
  • 褪黑激素补充剂
  • 草药补充剂
  • 其他的

按应用

  • 失眠治疗
  • 缓解焦虑
  • 其他的

按分销管道

  • 在线的
  • 超级市场/大卖场
  • 药局和药局
  • 专卖店

按地区

  • 北美洲
  • 美国
  • 加拿大
  • 墨西哥
  • 南美洲
  • 巴西
  • 阿根廷
  • 其他的
  • 欧洲
  • 英国
  • 德国
  • 法国
  • 西班牙
  • 其他的
  • 中东和非洲
  • 沙乌地阿拉伯
  • UAE
  • 其他的
  • 亚太地区
  • 中国
  • 日本
  • 韩国
  • 澳洲
  • 印度
  • 印尼
  • 泰国
  • 其他的

目录

第 1 章 简介

  • 市场概况
  • 市场定义
  • 研究范围
  • 市场区隔
  • 货币
  • 先决条件
  • 基准年和预测年时间表
  • 相关利益者的主要利益

第二章调查方法

  • 研究设计
  • 研究过程

第三章执行摘要

  • 主要发现
  • CXO观点

第四章 市场动态

  • 市场驱动因素
  • 市场限制
  • 波特五力分析
  • 产业价值链分析
  • 分析师观点

5. 非处方睡眠辅助药物市场按类型

  • 介绍
  • 抗组织胺药
  • 褪黑激素补充剂
  • 草药补充剂
  • 其他的

6. 非处方睡眠辅助产品市场（依应用）

  • 介绍
  • 失眠治疗
  • 缓解焦虑
  • 其他的

7. 非处方睡眠辅助产品市场（依分销管道）

  • 介绍
  • 在线的
  • 超级市场/大卖场
  • 药局和药局
  • 专卖店

8. 非处方睡眠辅助药物市场（按地区）

  • 介绍
  • 北美洲
    • 按类型
    • 按应用
    • 按分销管道
    • 按国家
  • 南美洲
    • 按类型
    • 按应用
    • 按分销管道
    • 按国家
  • 欧洲
    • 按类型
    • 按应用
    • 按分销管道
    • 按国家
  • 中东和非洲
    • 按类型
    • 按应用
    • 按分销管道
    • 按国家
  • 亚太地区
    • 按类型
    • 按应用
    • 按分销管道
    • 按国家

第九章竞争格局及分析

  • 主要企业和策略分析
  • 市场占有率分析
  • 合併、收购、协议和合作
  • 竞争仪錶板

第十章 公司简介

  • Pfizer Inc.
  • Sanofi SA
  • Johnson and Johnson
  • Reckitt Benckiser
  • Sundown Naturals
  • Proctor and Gamble
  • Bayer AG
  • Unilever
简介目录
Product Code: KSI061617252

The OTC Sleep Aids Medication Market is expected to grow at a CAGR of 4.89%, reaching a market size of US$25.526 billion in 2030 from US$20.105 billion in 2025

Over-the-counter (OTC) sleep aid medications are drugs available without a prescription, designed to help with occasional sleeplessness or insomnia. These medications are typically recommended for treating infrequent sleepless nights. Commonly used OTC sleep aids include diphenhydramine, doxylamine, melatonin, and valerian. The market for these products features well-known brands such as Unison SleepTabs, ZzzQuil, Tylenol, Nytol, and Sominex.The OTC sleep aids medication market encompasses the production, distribution, and sale of nonprescription sleeping pills and natural supplements aimed at managing occasional sleeplessness, mild insomnia, temporary sleep disturbances, jet lag, and general restlessness. This market includes antihistamine-based medications, melatonin supplements, and herbal remedies like valerian root and chamomile.The growth of the OTC sleep aid medication market is driven by several factors. The rising prevalence of sleep disorders is largely attributed to modern lifestyle changes such as stress, anxiety, irregular work schedules, and excessive screen time. These factors have led to an increase in sleep disorders becoming common. As people become more aware of the importance of sleep health, there is a growing demand for sleeping pills or natural supplements to address their sleep issues. Additionally, the accessibility of OTC medications contributes to the continued growth of this market. Furthermore, there is a notable trend toward natural and herbal sleep aid medications that is expected to further boost market growth.

Drivers of the OTC Sleep Aids Medication Market:

  • Rising Prevalence of Sleep Disorders: The modern lifestyle characterized by stress, anxiety, work pressure, and excessive screen time has led to a significant increase in individuals suffering from sleep disorders such as insomnia and parasomnia. According to data from the National Heart, Lung, and Blood Institute, approximately 50 to 70 million Americans experience sleep or wakefulness disorders. Additionally, the clinical guidelines for evaluating and managing chronic insomnia in adults estimate that around 33% to 50% of the adult population faces situational stress. These statistics indicate a growing trend in sleeplessness and suggest that the OTC sleep aid medication market will see substantial growth in the coming years.

Geographical Outlook of the OTC Sleep Aids Medication Market:

  • Asia-Pacific Expected to Be the Fastest-Growing Region: The OTC sleep aids medication market is segmented into North America, South America, Europe, the Middle East & Africa, and Asia-Pacific. During the forecast period, Asia-Pacific is projected to be the fastest-growing region due to increasing cases of sleep disorders linked to modern lifestyles. Rising economic conditions are enabling consumers to afford these medications. Additionally, there is heightened awareness among individuals regarding sleep-related disorders and their treatment options.

In contrast, North America is expected to maintain a significant share of the market due to its advanced healthcare infrastructure. The high prevalence of sleep disorders and supportive infrastructure for medication access are key factors driving market growth in this region.In summary, the OTC sleep aid medication market is poised for robust growth driven by increasing awareness of sleep health issues, rising demand for effective solutions targeting insomnia and related disorders, advancements in product formulations, and significant geographical developments-particularly within Asia-Pacific-that enhance this expanding market landscape.

Reasons for buying this report:-

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, other sub- segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape up future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decision to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data & forecasts from 2022 to 2030
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, Customer Behaviour, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information, and Key Developments among others)

The OTC Sleep Aids Medication Market has been segmented as following:

By Type

  • Antihistamine
  • Melatonin Supplements
  • Herbal Supplement
  • Others

By Application

  • Insomnia Treatment
  • Anxiety Relief
  • Others

By Distribution Channel

  • Online
  • Supermarkets/Hypermarkets
  • Pharmacies and Drugstores
  • Specialty Stores

By Geography

  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • United Kingdom
  • Germany
  • France
  • Spain
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Others
  • Asia Pacific
  • China
  • Japan
  • South Korea
  • Australia
  • India
  • Indonesia
  • Thailand
  • Others

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. Market Overview
  • 1.2. Market Definition
  • 1.3. Scope of the Study
  • 1.4. Market Segmentation
  • 1.5. Currency
  • 1.6. Assumptions
  • 1.7. Base and Forecast Years Timeline
  • 1.8. Key Benefits to the Stakeholder

2. RESEARCH METHODOLOGY

  • 2.1. Research Design
  • 2.2. Research Processes

3. EXECUTIVE SUMMARY

  • 3.1. Key Findings
  • 3.2. CXO Perspective

4. MARKET DYNAMICS

  • 4.1. Market Drivers
  • 4.2. Market Restraints
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers
    • 4.3.2. Bargaining Power of Buyers
    • 4.3.3. Threat of New Entrants
    • 4.3.4. Threat of Substitutes
    • 4.3.5. Competitive Rivalry in the Industry
  • 4.4. Industry Value Chain Analysis
  • 4.5. Analyst View

5. OTC SLEEP AIDS MEDICATION MARKET BY TYPE

  • 5.1. Introduction
  • 5.2. Antihistamine
  • 5.3. Melatonin Supplements
  • 5.4. Herbal Supplements
  • 5.5. Others

6. OTC SLEEP AIDS MEDICATION MARKET BY APPLICATION

  • 6.1. Introduction
  • 6.2. Insomnia Treatment
  • 6.3. Anxiety Relief
  • 6.4. Others

7. OTC SLEEP AIDS MEDICATION MARKET BY DISTRIBUTION CHANNEL

  • 7.1. Introduction
  • 7.2. Online
  • 7.3. Supermarkets/Hypermarkets
  • 7.4. Pharmacies and Drugstores
  • 7.5. Specialty Stores

8. OTC SLEEP AIDS MEDICATION MARKET BY GEOGRAPHY

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. By Type
    • 8.2.2. By Application
    • 8.2.3. By Distribution Channel
    • 8.2.4. By Country
      • 8.2.4.1. USA
      • 8.2.4.2. Canada
      • 8.2.4.3. Mexico
  • 8.3. South America
    • 8.3.1. By Type
    • 8.3.2. By Application
    • 8.3.3. By Distribution Channel
    • 8.3.4. By Country
      • 8.3.4.1. Brazil
      • 8.3.4.2. Argentina
      • 8.3.4.3. Others
  • 8.4. Europe
    • 8.4.1. By Type
    • 8.4.2. By Application
    • 8.4.3. By Distribution Channel
    • 8.4.4. By Country
      • 8.4.4.1. United Kingdom
      • 8.4.4.2. Germany
      • 8.4.4.3. France
      • 8.4.4.4. Spain
      • 8.4.4.5. Others
  • 8.5. Middle East and Africa
    • 8.5.1. By Type
    • 8.5.2. By Application
    • 8.5.3. By Distribution Channel
    • 8.5.4. By Country
      • 8.5.4.1. Saudi Arabia
      • 8.5.4.2. UAE
      • 8.5.4.3. Others
  • 8.6. Asia Pacific
    • 8.6.1. By Type
    • 8.6.2. By Application
    • 8.6.3. By Distribution Channel
    • 8.6.4. By Country
      • 8.6.4.1. China
      • 8.6.4.2. Japan
      • 8.6.4.3. South Korea
      • 8.6.4.4. Australia
      • 8.6.4.5. India
      • 8.6.4.6. Indonesia
      • 8.6.4.7. Thailand
      • 8.6.4.8. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 9.1. Major Players and Strategy Analysis
  • 9.2. Market Share Analysis
  • 9.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 9.4. Competitive Dashboard

10. COMPANY PROFILES

  • 10.1. Pfizer Inc.
  • 10.2. Sanofi S.A.
  • 10.3. Johnson and Johnson
  • 10.4. Reckitt Benckiser
  • 10.5. Sundown Naturals
  • 10.6. Proctor and Gamble
  • 10.7. Bayer AG
  • 10.8. Unilever